Found: 66
Select item for more details and to access through your institution.
Successful Conversion Surgery after Ceritinib Monotherapy in a Patient with Advanced Inflammatory Myofibroblastic Tumor Harboring SQSTM1-ALK fusion.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 2, p. 77, doi. 10.4103/ejcrp.eJCRP-D-23-00048
- By:
- Publication type:
- Article
Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 18, doi. 10.4103/ejcrp.eJCRP-D-23-00050
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 28, doi. 10.4103/ejcrp.eJCRP-D-23-00043
- By:
- Publication type:
- Article
Combined immune checkpoint inhibitors, immunotherapy with picibanil-based intraperitoneal imiquimod, and chemotherapy in cases of advanced cervical cancer and failure of concurrent chemoradiation therapy: A new clinical paradigm.
- Published in:
- Journal of Cancer Research & Practice, 2022, v. 9, n. 4, p. 165, doi. 10.4103/2311-3006.362640
- By:
- Publication type:
- Article
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 357, doi. 10.3390/jpm11050357
- By:
- Publication type:
- Article
Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 3, p. 267
- By:
- Publication type:
- Article
Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 602, doi. 10.3390/ijms24010602
- By:
- Publication type:
- Article
EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13451, doi. 10.3390/ijms232113451
- By:
- Publication type:
- Article
Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11809, doi. 10.3390/ijms231911809
- By:
- Publication type:
- Article
Prevalence of severe depressive symptoms increases as death approaches and is associated with disease burden, tangible social support, and high self-perceived burden to others.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A cost‐utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan.
- Published in:
- Cancer Reports, 2021, v. 4, n. 6, p. 1, doi. 10.1002/cnr2.1399
- By:
- Publication type:
- Article
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 474, doi. 10.3390/vaccines12050474
- By:
- Publication type:
- Article
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 703, doi. 10.3390/vaccines8040703
- By:
- Publication type:
- Article
Precision Medicine in Cholangiocarcinoma: Past, Present, and Future.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 6, p. 829, doi. 10.3390/life12060829
- By:
- Publication type:
- Article
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 11, p. 276, doi. 10.3390/life10110276
- By:
- Publication type:
- Article
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2ndgeneration EGFR-tyrosine kinase inhibitors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1249106
- By:
- Publication type:
- Article
Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.982196
- By:
- Publication type:
- Article
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 403, doi. 10.1111/ajco.12574
- By:
- Publication type:
- Article
A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction.
- Published in:
- Biological Trace Element Research, 2023, v. 201, n. 12, p. 5540, doi. 10.1007/s12011-023-03618-y
- By:
- Publication type:
- Article
Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy.
- Published in:
- Scientific Reports, 2016, p. 31423, doi. 10.1038/srep31423
- By:
- Publication type:
- Article
Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 11, p. 1626, doi. 10.3390/biom11111626
- By:
- Publication type:
- Article
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 11, p. 1529, doi. 10.3390/biom10111529
- By:
- Publication type:
- Article
Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 11, p. 1474, doi. 10.3390/biom10111474
- By:
- Publication type:
- Article
Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 7, p. e278, doi. 10.1111/ijd.15468
- By:
- Publication type:
- Article
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case–control cohort study.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 2, p. 179, doi. 10.1111/ijd.15099
- By:
- Publication type:
- Article
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5095, doi. 10.3390/cancers14205095
- By:
- Publication type:
- Article
Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4642, doi. 10.3390/cancers14194642
- By:
- Publication type:
- Article
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 977, doi. 10.3390/cancers14040977
- By:
- Publication type:
- Article
WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3876, doi. 10.3390/cancers13153876
- By:
- Publication type:
- Article
Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3139, doi. 10.3390/cancers13133139
- By:
- Publication type:
- Article
A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2587, doi. 10.3390/cancers13112587
- By:
- Publication type:
- Article
Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 679, doi. 10.3390/cancers11050679
- By:
- Publication type:
- Article
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 424, doi. 10.3390/cancers11030424
- By:
- Publication type:
- Article
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 3, doi. 10.3390/cancers11010003
- By:
- Publication type:
- Article
Update of Diagnosis and Targeted Therapy for ALK<sup>+</sup> Inflammation Myofibroblastic Tumor.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1683, doi. 10.1007/s11864-023-01144-6
- By:
- Publication type:
- Article
Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Using aprepitant as secondary antiemetic prophylaxis for cancer patients with cisplatin-induced emesis.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 10, p. 2357, doi. 10.1007/s00520-011-1345-z
- By:
- Publication type:
- Article
Fetal–neonatal and maternal outcomes in women with Sjögren syndrome: a population-based registry linkage study.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2820, doi. 10.1093/rheumatology/keac711
- By:
- Publication type:
- Article
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2548, doi. 10.1111/1759-7714.15017
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 12, doi. 10.1111/1759-7714.14537
- By:
- Publication type:
- Article
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 4, p. 348, doi. 10.1111/1759-7714.14674
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1888, doi. 10.1111/1759-7714.14272
- By:
- Publication type:
- Article
Genomic Landscapes of Acral Melanomas in East Asia.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2021, v. 18, n. 1, p. 83, doi. 10.21873/cgp.20243
- By:
- Publication type:
- Article
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 9, p. 2772, doi. 10.7150/ijbs.79126
- By:
- Publication type:
- Article
Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study.
- Published in:
- Diseases of the Esophagus, 2023, v. 36, n. 11, p. 1, doi. 10.1093/dote/doad031
- By:
- Publication type:
- Article